Imulsion extract is a refined concentrate of natural imulsion that is principally responsible for the efficient generation of energy from imulsion through the Lightmass Process. Because purified imulsion extract, on a per unit basis, is far more efficient at energy generation than crude, unprocessed imulsion, the purification and distillation of imulsion extract has become highly exploited by many corporate and governmental groups attempting to harness imulsion as a practical fuel source.
However, it was in 2531 that DeMarshall et. al at the Bastion Public Health Service identified that imulsion extract is a potent mutagen and health risk to the adult human, raising extraordinary concerns to exposing human workers to high concentrations of imulsion extract and vitally threatening the imulsion industry. Numerous subsequent reports, including seminal reports by Davis et. al and Murchie et. al, have identified numerous naturally-occurring small-molecules in imulsion extract that are responsible for its potent mutagenic effects.
The following is an incomplete list of small-molecules in imulsion extract that are believed to mediate its cytotoxic and mutagenic properties, at least in part:
- Teratomorphin ("IMC-1"): ACVR1 and FGFR3 agonist
- Cephalonikin ("IMC-2"): Neuronal genomic DNA mutagen
- Cyclogenol ("EP 163498"): CDKN1B inhibitor
- Trophopentin ("EP 287561"): IGFRI agonist
- Fibrosporine ("EP 613593"): TGFβRI agonist
- Maldorsalin ("EP 870500"): FGFR1 agonist
- ↑ DeMarshall et. al. (2531). Novel mutagenic properties of imulsion extract. Nature (538): 1749—1953.
- ↑ 2.0 2.1 2.2 Davis et. al. (2532). Identification of mutagenic small molecules from imulsion extract. Nature (541): 173-177.
- ↑ 3.0 3.1 Murchie et. al (2532). Behavioral defects induced by imulsion extract mediated by a defined neuronal genetic mutagen. Nature (541): 173-177.